SIGNIFOR LAR is the first and only long-acting, pituitary-targeted therapy for Cushing’s disease with proven clinical efficacy.2,3
SIGNIFOR LAR targets the receptors most responsible for ACTH oversecretion to help settle the storm of cortisol overproduction.1
SIGNIFOR LAR is a long-acting intramuscular injection given by a trained healthcare professional once every 4 weeks (28 days).1
References: 1. SIGNIFOR LAR (pasireotide) for injectable suspension, for intramuscular use [prescribing information]. Lebanon, NJ: Recordati Rare Diseases Inc.; 2020. 2. Ciato D, et al. Expert Opin Investig Drugs. 2017;26(1):75-84. 3. Langlois F, et al. Front Endocrinol. 2018;9(164)1-12.